Matthew P. Ottmer

Matthew P. Ottmer has filed trades across 2 companies (mainly through SEC (Form 4)), most often in Voyager Therapeutics, Inc. and Momenta Pharmaceuticals Inc. We count 3 filings; the first trade dates from 13 April 2016 and the latest from 21 January 2020.

No open-market purchase appears, only 1 sale worth €45k. The rest of the record consists of 2 share grants. So far in 2020, the count stands at no purchases and 1 sale.

The latest filing, published on 29 January 2020, reports an open-market sale of €45k in Voyager Therapeutics, Inc. Typically, a trade is published a median of 6 days after it takes place. Section 16 rules allow two business days to file each Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.